Physician profile
Dolly Pham
NPI 1487386017
$16,907.82
in general payments reported to CMS, 2019-2025
8 companies · $481 in 2025
The $481 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $7,358 · 2023: $8,916 · 2024: $153 · 2025: $481.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,550.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,549.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be INC | $15,716.39 | 2022-2023 | M22 |
| Eisai INC. | $393.86 | 2024-2025 | |
| Galderma Laboratories, L.P. | $376.75 | 2022 | |
| Alexion Pharmaceuticals, INC. | $172.91 | 2023-2025 | Ultomiris |
| Abbvie INC. | $158.28 | 2023-2024 | |
| Janssen Biotech, INC. | $37.30 | 2025 | Tremfya |
| Lilly USA, LLC | $31.26 | 2025 | Kisunla |
| Ucb, INC. | $21.07 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dolly Pham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.